FFT Wealth Management LLC Has $472,000 Position in Agilent Technologies, Inc. (NYSE:A)

FFT Wealth Management LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 19.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,516 shares of the medical research company’s stock after acquiring an additional 578 shares during the period. FFT Wealth Management LLC’s holdings in Agilent Technologies were worth $472,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in A. Massachusetts Financial Services Co. MA grew its holdings in Agilent Technologies by 3.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after purchasing an additional 525,214 shares during the period. State Street Corp boosted its position in shares of Agilent Technologies by 1.2% during the 3rd quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock worth $1,903,498,000 after purchasing an additional 158,175 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Agilent Technologies by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock valued at $1,028,241,000 after buying an additional 30,610 shares during the period. Van ECK Associates Corp increased its position in Agilent Technologies by 8.7% in the 4th quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock valued at $434,625,000 after buying an additional 258,358 shares in the last quarter. Finally, Nordea Investment Management AB raised its stake in Agilent Technologies by 2.6% during the 4th quarter. Nordea Investment Management AB now owns 3,198,715 shares of the medical research company’s stock worth $431,603,000 after buying an additional 80,819 shares during the period.

Agilent Technologies Stock Performance

Shares of A opened at $134.05 on Wednesday. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The stock’s fifty day moving average price is $140.87 and its two-hundred day moving average price is $139.31. The firm has a market cap of $38.24 billion, a PE ratio of 30.33, a PEG ratio of 3.66 and a beta of 1.07.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. The business had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The firm’s quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the business posted $1.38 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is currently 22.40%.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Wall Street Analyst Weigh In

Several research firms have recently commented on A. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $135.00 to $145.00 in a research note on Monday, February 10th. JPMorgan Chase & Co. lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Bank of America reduced their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Finally, Wells Fargo & Company lowered their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $144.38.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.